Kintara Therapeutics Inc (KTRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KTRA | MRNA | BMY | AMGN | GILD |
| Company | Kintara Therapeutics Inc | Moderna Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.1498 | 123.15 | 43.56 | 309.53 | 65.18 |
| High | 0.1587 | 125.50 | 43.98 | 311.24 | 65.22 |
| Low | 0.1486 | 121.68 | 43.50 | 306.32 | 64.66 |
| Last | 0.1574 | 124.28 | 43.89 | 311.59 | 64.65 |
| Change | +0.0088 | +2.39 | +0.22 | +4.28 | -0.27 |
| % Change | +5.92% | +1.96% | +0.50% | +1.39% | -0.42% |
| Volume | 1,440,355 | 1,035,349 | 2,571,071 | 718,260 | 1,396,830 |
| 20-Day Average Volume | 6,600,557 | 3,190,581 | 13,940,655 | 2,794,562 | 7,224,732 |
| Previous Close | 0.1486 | 121.89 | 43.67 | 307.31 | 64.92 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.1372 | 111.39 | 46.13 | 279.36 | 66.11 |
| 20-Day Raw Stochastic | 59.04% | 82.55% | 9.11% | 80.89% | 10.14% |
| 20-Day Relative Strength | 55.84% | 64.97% | 30.48% | 67.27% | 32.30% |
| Weighted Alpha | -59.58 | +11.15 | -36.38 | +34.40 | -21.31 |
| Today's Opinion | 8% Sell | 100% Buy | 100% Sell | 56% Buy | 100% Sell |
| Previous Opinion | 8% Sell | 100% Buy | 100% Sell | 56% Buy | 100% Sell |
| Last Month's Opinion | 40% Sell | 88% Buy | 48% Sell | 40% Sell | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.45% since 05/02/24 | -1.54% since 05/02/24 | +0.46% since 05/02/24 | +11.63% since 05/02/24 | -0.86% since 05/02/24 |
| Low | 0.1450 on 05/06/24 | 118.68 on 05/07/24 | 43.49 on 05/09/24 | 297.52 on 05/06/24 | 64.33 on 05/03/24 |
| High | 0.1624 on 05/03/24 | 126.40 on 05/03/24 | 44.62 on 05/06/24 | 322.60 on 05/03/24 | 66.14 on 05/07/24 |
| 1-Month | |||||
| %Chg | +18.83% since 04/09/24 | +10.81% since 04/09/24 | -14.92% since 04/09/24 | +14.95% since 04/09/24 | -7.40% since 04/09/24 |
| Low | 0.1010 on 04/18/24 | 99.30 on 04/22/24 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 |
| High | 0.1950 on 04/26/24 | 128.81 on 05/02/24 | 51.28 on 04/10/24 | 322.60 on 05/03/24 | 69.76 on 04/10/24 |
| 3-Month | |||||
| %Chg | +25.70% since 02/09/24 | +41.47% since 02/09/24 | -11.87% since 02/09/24 | +6.75% since 02/09/24 | -12.09% since 02/09/24 |
| Low | 0.0810 on 03/12/24 | 84.06 on 02/13/24 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 |
| High | 0.2400 on 04/03/24 | 128.81 on 05/02/24 | 55.03 on 03/13/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 |
| 6-Month | |||||
| %Chg | -60.37% since 11/09/23 | +77.90% since 11/09/23 | -12.91% since 11/09/23 | +17.69% since 11/09/23 | -13.62% since 11/09/23 |
| Low | 0.0810 on 03/12/24 | 67.62 on 11/13/23 | 43.33 on 05/02/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 |
| High | 0.6780 on 11/10/23 | 128.81 on 05/02/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,801 | 46,713,120 | 88,523,448 | 164,851,840 | 80,830,400 |
| Shares Outstanding, K | 39,038 | 383,240 | 2,027,100 | 536,435 | 1,245,077 |
| Annual Sales | 0 | 6,848,000,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 |
| Annual Net Income | -14,650,000 | -4,714,000,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 167,000,000 | 11,865,000,000 | 7,447,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -1,020,000 | -1,175,000,000 | -11,911,000,000 | -113,000,000 | -4,170,000,000 |
| 60-Month Beta | 0.42 | 1.57 | 0.45 | 0.60 | 0.22 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 02/14/24 | -3.07 on 05/02/24 | -4.40 on 04/25/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 04/25/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | N/A | 04/04/24 | 05/16/24 | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 41.94 | 16.12 | 16.24 |